Bausch Health Companies Inc. Increase (Decrease) in Accounts Payable and Accrued Liabilities
Bausch Health Companies Inc. (BHC) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$77.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-07-30
- Bausch Health Companies Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was $73.00M, a 55.21% decline year-over-year.
- Bausch Health Companies Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was -$150.00M.
- Bausch Health Companies Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was -$284.00M, a 1283.33% decline year-over-year.
- Bausch Health Companies Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was $144.00M, a 0.00% change year-over-year.
- Bausch Health Companies Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was -$76.00M, a 121.29% decline from fiscal 2024.
- Bausch Health Companies Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was $357.00M, a 125.95% increase from fiscal 2023.
- Bausch Health Companies Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $158.00M.
- Bausch Health Companies Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was -$75.00M, a 161.98% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $73.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$77.00M 10-Q · filed 2026-07-30 | -$361.00M derived: sum of 3 quarters · filed 2026-07-30 | -$217.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | -$150.00M 10-Q · filed 2026-04-30 | -$434.00M derived: sum of 2 quarters · filed 2026-04-30 | -$290.00M derived: sum of 3 quarters · filed 2026-04-30 | -$127.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | -$284.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$140.00M derived: sum of 2 quarters · filed 2026-02-19 | $23.00M derived: sum of 3 quarters · filed 2026-07-30 | -$76.00M 10-K · filed 2026-02-19 | ||||
| 2025-09-30 | $144.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $307.00M derived: sum of 2 quarters · filed 2026-07-30 | $208.00M 10-Q · filed 2025-10-30 | $232.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | $163.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $64.00M 10-Q · filed 2026-07-30 | $88.00M derived: sum of 3 quarters · filed 2026-07-30 | $232.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | -$99.00M 10-Q · filed 2026-04-30 | -$75.00M derived: sum of 2 quarters · filed 2026-04-30 | $69.00M derived: sum of 3 quarters · filed 2026-04-30 | $207.00M derived: sum of 4 quarters · filed 2026-04-30 | ||||
| 2024-12-31 | $24.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $168.00M derived: sum of 2 quarters · filed 2026-02-19 | $306.00M derived: sum of 3 quarters · filed 2026-02-19 | $357.00M 10-K · filed 2026-02-19 | ||||
| 2024-09-30 | $144.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $282.00M derived: sum of 2 quarters · filed 2025-10-30 | $333.00M 10-Q · filed 2025-10-30 | $430.00M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2024-06-30 | $138.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $189.00M 10-Q · filed 2025-07-31 | $286.00M derived: sum of 3 quarters · filed 2026-02-19 | $452.00M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2024-03-31 | $51.00M 10-Q · filed 2025-05-01 | $148.00M derived: sum of 2 quarters · filed 2026-02-19 | $314.00M derived: sum of 3 quarters · filed 2026-02-19 | $217.00M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2023-12-31 | $97.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $263.00M derived: sum of 2 quarters · filed 2026-02-19 | $166.00M derived: sum of 3 quarters · filed 2026-02-19 | $158.00M 10-K · filed 2026-02-19 | ||||
| 2023-09-30 | $166.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $69.00M derived: sum of 2 quarters · filed 2024-10-31 | $61.00M 10-Q · filed 2024-10-31 | $108.00M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2023-06-30 | -$97.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$105.00M 10-Q · filed 2024-08-01 | -$58.00M derived: sum of 3 quarters · filed 2025-02-20 | -$154.00M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2023-03-31 | -$8.00M 10-Q · filed 2024-05-02 | $39.00M derived: sum of 2 quarters · filed 2025-02-20 | -$57.00M derived: sum of 3 quarters · filed 2025-02-20 | -$8.00M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2022-12-31 | $47.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | -$49.00M derived: sum of 2 quarters · filed 2025-02-20 | $0.00 derived: sum of 3 quarters · filed 2025-02-20 | -$75.00M 10-K · filed 2025-02-20 | ||||
| 2022-09-30 | -$96.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$47.00M derived: sum of 2 quarters · filed 2023-11-02 | -$122.00M 10-Q · filed 2023-11-02 | -$292.00M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-06-30 | $49.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$26.00M 10-Q · filed 2023-08-03 | -$196.00M derived: sum of 3 quarters · filed 2024-02-22 | -$150.00M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-03-31 | -$75.00M 10-Q · filed 2023-05-04 | -$245.00M derived: sum of 2 quarters · filed 2024-02-22 | -$199.00M derived: sum of 3 quarters · filed 2024-02-22 | -$69.00M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2021-12-31 | -$170.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$124.00M derived: sum of 2 quarters · filed 2024-02-22 | $6.00M derived: sum of 3 quarters · filed 2024-02-22 | $121.00M 10-K · filed 2024-02-22 | ||||
| 2021-09-30 | $46.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $176.00M derived: sum of 2 quarters · filed 2022-11-03 | $291.00M 10-Q · filed 2022-11-03 | $106.00M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-06-30 | $130.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $245.00M 10-Q · filed 2022-08-09 | $60.00M derived: sum of 3 quarters · filed 2023-02-23 | $130.00M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-03-31 | $115.00M 10-Q · filed 2022-05-10 | -$70.00M derived: sum of 2 quarters · filed 2023-02-23 | $0.00 derived: sum of 3 quarters · filed 2023-02-23 | -$271.00M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2020-12-31 | -$185.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | -$115.00M derived: sum of 2 quarters · filed 2023-02-23 | -$386.00M derived: sum of 3 quarters · filed 2023-02-23 | -$471.00M 10-K · filed 2023-02-23 | ||||
| 2020-09-30 | $70.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | -$201.00M derived: sum of 2 quarters · filed 2021-11-02 | -$286.00M 10-Q · filed 2021-11-02 | -$402.00M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2020-06-30 | -$271.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | -$356.00M 10-Q · filed 2021-08-03 | -$472.00M derived: sum of 3 quarters · filed 2022-05-11 | -$446.00M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2020-03-31 | -$85.00M 10-Q · filed 2021-05-04 | -$201.00M derived: sum of 2 quarters · filed 2022-05-11 | -$175.00M derived: sum of 3 quarters · filed 2022-05-11 | -$230.00M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2019-12-31 | -$116.00M derived: 8-K 12 month − 10-Q 9 month · filed 2022-05-11 | -$90.00M derived: sum of 2 quarters · filed 2022-05-11 | -$145.00M derived: sum of 3 quarters · filed 2022-05-11 | -$149.00M 8-K · filed 2022-05-11 | ||||
| 2019-09-30 | $26.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03 | -$29.00M derived: sum of 2 quarters · filed 2020-11-03 | -$33.00M 10-Q · filed 2020-11-03 | -$261.00M derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2019-06-30 | -$55.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$59.00M 10-Q · filed 2020-08-06 | -$287.00M derived: sum of 3 quarters · filed 2021-05-04 | -$203.00M derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2019-03-31 | -$4.00M 10-Q · filed 2020-05-07 | -$232.00M derived: sum of 2 quarters · filed 2021-05-04 | -$148.00M derived: sum of 3 quarters · filed 2021-05-04 | -$214.00M derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2018-12-31 | -$228.00M derived: 8-K 12 month − 10-Q 9 month · filed 2021-05-04 | -$144.00M derived: sum of 2 quarters · filed 2021-05-04 | -$210.00M derived: sum of 3 quarters · filed 2021-05-04 | -$121.00M 8-K · filed 2021-05-04 | ||||
| 2018-09-30 | $84.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $18.00M derived: sum of 2 quarters · filed 2019-11-04 | $107.00M 10-Q · filed 2019-11-04 | $195.00M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-06-30 | -$66.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $23.00M 10-Q · filed 2019-08-06 | $111.00M derived: sum of 3 quarters · filed 2020-02-19 | $254.00M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-03-31 | $89.00M 10-Q · filed 2019-05-06 | $177.00M derived: sum of 2 quarters · filed 2020-02-19 | $320.00M derived: sum of 3 quarters · filed 2020-02-19 | $280.00M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2017-12-31 | $88.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $231.00M derived: sum of 2 quarters · filed 2020-02-19 | $191.00M derived: sum of 3 quarters · filed 2020-02-19 | $387.00M 10-K · filed 2020-02-19 | ||||
| 2017-09-30 | $143.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $103.00M derived: sum of 2 quarters · filed 2018-11-06 | $299.00M 10-Q · filed 2018-11-06 | $125.00M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-06-30 | -$40.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $156.00M 10-Q · filed 2018-08-07 | -$18.00M derived: sum of 3 quarters · filed 2019-02-20 | -$23.00M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-03-31 | $196.00M 10-Q · filed 2018-05-08 | $22.00M derived: sum of 2 quarters · filed 2019-02-20 | $17.00M derived: sum of 3 quarters · filed 2019-02-20 | $78.00M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2016-12-31 | -$174.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | -$179.00M derived: sum of 2 quarters · filed 2019-02-20 | -$118.00M derived: sum of 3 quarters · filed 2019-02-20 | -$144.00M 10-K · filed 2019-02-20 | ||||
| 2016-09-30 | -$5.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $56.00M derived: sum of 2 quarters · filed 2017-11-07 | $30.00M 10-Q · filed 2017-11-07 | $29.20M 10-Q · filed 2016-11-09 | $10.30M derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2016-06-30 | $61.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $35.00M 10-Q · filed 2017-08-08 | $34.10M 10-Q · filed 2016-08-09 | $15.30M derived: sum of 3 quarters · filed 2018-08-10 | $296.90M derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2016-03-31 | -$26.00M 10-Q · filed 2017-05-09 | -$25.90M 10-Q · filed 2016-06-07 | -$45.70M derived: sum of 2 quarters · filed 2018-08-10 | $235.90M derived: sum of 3 quarters · filed 2018-08-10 | $347.10M derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2015-12-31 | -$19.70M derived: 8-K 12 month − 10-Q 9 month · filed 2018-08-10 | $261.90M derived: sum of 2 quarters · filed 2018-08-10 | $373.10M derived: sum of 3 quarters · filed 2018-08-10 | $325.00M 8-K · filed 2018-08-10 | $170.30M 10-K · filed 2016-04-29 | |||
| 2015-09-30 | $281.60M 10-Q · filed 2015-10-26 | $392.80M derived: sum of 2 quarters · filed 2015-10-26 | $344.70M 10-Q · filed 2016-11-09 | $334.10M 10-Q · filed 2015-10-26 | $658.70M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-06-30 | $111.20M 10-Q · filed 2015-07-28 | $55.70M 10-Q · filed 2016-08-09 | $52.50M 10-Q · filed 2015-07-28 | $377.10M derived: sum of 3 quarters · filed 2017-03-01 | $467.80M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-03-31 | -$33.70M 10-Q · filed 2016-06-07 | -$58.70M 10-Q · filed 2015-04-30 | $265.90M derived: sum of 2 quarters · filed 2017-03-01 | $356.60M derived: sum of 3 quarters · filed 2017-03-01 | $231.70M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2014-12-31 | $299.60M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $390.30M derived: sum of 2 quarters · filed 2017-03-01 | $265.40M derived: sum of 3 quarters · filed 2017-03-01 | $318.00M 10-K · filed 2017-03-01 | $188.60M 10-K · filed 2015-02-25 | |||
| 2014-09-30 | $90.70M 10-Q · filed 2015-10-26 | -$34.20M derived: sum of 2 quarters · filed 2015-10-26 | $18.40M 10-Q · filed 2015-10-26 | -$60.80M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2014-06-30 | -$124.90M 10-Q · filed 2015-07-28 | -$72.30M 10-Q · filed 2015-07-28 | -$151.50M derived: sum of 3 quarters · filed 2016-04-29 | -$205.40M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2014-03-31 | $52.60M 10-Q · filed 2015-04-30 | -$26.60M derived: sum of 2 quarters · filed 2016-04-29 | -$80.50M derived: sum of 3 quarters · filed 2016-04-29 | -$33.10M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2013-12-31 | -$79.20M derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-29 | -$133.10M derived: sum of 2 quarters · filed 2016-04-29 | -$85.70M derived: sum of 3 quarters · filed 2016-04-29 | -$76.50M 10-K · filed 2016-04-29 | -$76.55M 10-K · filed 2014-02-28 | |||
| 2013-09-30 | -$53.90M 10-Q · filed 2014-10-24 | -$53.86M 10-Q · filed 2013-11-01 | -$6.50M derived: sum of 2 quarters · filed 2014-10-24 | $2.70M 10-Q · filed 2014-10-24 | $2.71M 10-Q · filed 2013-11-01 | -$50.00M derived: sum of 4 quarters · filed 2015-02-25 | ||
| 2013-06-30 | $47.40M 10-Q · filed 2014-08-01 | $47.38M 10-Q · filed 2013-08-07 | $56.60M 10-Q · filed 2014-08-01 | $56.57M 10-Q · filed 2013-08-07 | $3.90M derived: sum of 3 quarters · filed 2015-02-25 | $87.94M derived: sum of 4 quarters · filed 2015-02-25 | ||
| 2013-03-31 | $9.20M 10-Q · filed 2014-05-09 | $9.19M 10-Q · filed 2013-05-03 | -$43.50M derived: sum of 2 quarters · filed 2015-02-25 | $40.54M derived: sum of 3 quarters · filed 2015-02-25 | $16.39M derived: sum of 4 quarters · filed 2015-02-25 | |||
| 2012-12-31 | -$52.70M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $31.34M derived: sum of 2 quarters · filed 2015-02-25 | $7.18M derived: sum of 3 quarters · filed 2015-02-25 | -$8.40M 10-K · filed 2015-02-25 | -$29.07M 10-K · filed 2013-02-28 | |||
| 2012-09-30 | $84.04M 10-Q · filed 2013-11-01 | $84.35M 10-Q · filed 2012-11-05 | $59.88M derived: sum of 2 quarters · filed 2013-11-01 | $44.30M 10-Q · filed 2013-11-01 | $58.16M 10-Q · filed 2012-11-05 | $48.59M derived: sum of 4 quarters · filed 2014-02-28 | ||
| 2012-06-30 | -$24.16M 10-Q · filed 2013-08-07 | -$9.04M 10-Q · filed 2012-08-03 | -$39.74M 10-Q · filed 2013-08-07 | -$26.20M 10-Q · filed 2012-08-03 | -$35.45M derived: sum of 3 quarters · filed 2014-02-28 | $2.17M derived: sum of 4 quarters · filed 2014-02-28 | ||
| 2012-03-31 | -$15.59M 10-Q · filed 2013-05-03 | -$11.29M derived: sum of 2 quarters · filed 2014-02-28 | $26.32M derived: sum of 3 quarters · filed 2014-02-28 | $465.00K derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2011-12-31 | $4.29M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $41.91M derived: sum of 2 quarters · filed 2014-02-28 | $16.05M derived: sum of 3 quarters · filed 2014-02-28 | $42.07M 10-K · filed 2014-02-28 | $57.56M 10-K · filed 2013-02-28 | |||
| 2011-09-30 | $37.62M 10-Q · filed 2012-11-05 | $11.76M derived: sum of 2 quarters · filed 2012-11-05 | $37.77M 10-Q · filed 2012-11-05 | |||||
| 2011-06-30 | -$25.86M 10-Q · filed 2012-08-03 | $157.00K 10-Q · filed 2012-08-03 | ||||||
| 2010-12-31 | -$52.19M 10-K · filed 2013-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |